BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 4.05.2001

Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Postmarketing Expedited Safety Reports; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Providing Regulatory Submissions in Electronic Format--Postmarketing Expedited Safety Reports." This is one in a series of guidance documents on providing regulatory submissions to FDA in electronic format. This specific guidance discusses issues related to the electronic submission of postmarketing expedited safety reports for drug products marketed for human use with new drug applications (NDAs) and abbreviated new drug applications (ANDAs), prescription drug products marketed for human use without an approved NDA or ANDA, and therapeutic biological products marketed for human use with biologic license applications (BLAs). This guidance does not apply to vaccines. The submission of these reports in an electronic format will significantly improve the agency's efficiency in processing, archiving, and reviewing the reports.

Source: Federal Register — Food and Drug AdministrationOpen original release →